
AOA Dx
Blood Test for Early Detection of Ovarian Cancer
Monthly revenue–Not shared yet
Rank–Unranked
Last 30 days–Growth in MRR
Revenue per founder–– founders
About AOA Dx
AOA Dx is developing the next frontier in early-stage cancer detection for women through our pioneering work in glycolipids and proprietary biomarker technology.
Discover more startups
Browse the board →MRR
$250K
Last 30 days
0%
Founder
Valon Asani
MRR
$250K
Last 30 days
0%
Founder
Charlie Choi
MRR
$250K
Last 30 days
–
Founder
Nicolas Vandenberghe